Back

COVaRiPAD

Official Title

COVID-19 Vaccine Responses in Patients with Autoimmune Disease

Study Details

The purpose of this study is to evaluate the effectiveness and safety of COVID-19 vaccination in patients with autoimmune disease.

Principal Investigator

Dr. Alfred Kim

IRB Number

202012084

Eligibility

1. Participants must be at least 18 years old
2. Participants must have documented autoimmune disease
3. Participants must not have been previously vaccinated for COVID-19

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back